Studying C-methionine Uptake in Breast Cancer with PET
Author Information
Author(s): S. Leskinen-Kallio, K. Nagren, P. Lehikoinen, U. Ruotsalainen, H. Joensuu
Primary Institution: Turku University Central Hospital
Hypothesis
Can C-methionine uptake be used to image breast cancer and assess its proliferation rate?
Conclusion
C-methionine uptake can effectively image both primary and metastatic breast cancer and correlates with the proliferation rate of the tumors.
Supporting Evidence
- All malignant tumors larger than 30mm accumulated C-methionine.
- Strong uptake of C-methionine was associated with a large S-phase fraction.
- The uptake of C-methionine in normal breast tissue was low, providing good contrast with cancer.
Takeaway
Doctors used a special scan to see how much a substance called C-methionine is taken up by breast cancer. They found that more of it is taken up by bigger and faster-growing tumors.
Methodology
Patients underwent PET scans after being injected with C-methionine, and the uptake was measured and correlated with tumor size and S-phase fraction.
Limitations
The study's sample size was small, and the correlation between C-methionine uptake and tumor size may not apply to smaller tumors.
Participant Demographics
The study included 14 patients, primarily women, with various types of breast cancer.
Statistical Information
P-Value
0.01
Confidence Interval
95%
Statistical Significance
p=0.01
Want to read the original?
Access the complete publication on the publisher's website